Natera

Natera™ is a global leader in cell-free DNA (cfDNA) testing, dedicated to oncology, women’s health, and organ health. Our aim is to make personalized genetic testing and diagnostics part of the standard of care to protect health and enable earlier and more targeted interventions that lead to longer, healthier lives. Where some set out to build a test, we set out to achieve a mission: change the management of disease worldwide by using DNA testing to proactively inform treatment. Through a cfDNA technology platform approach, we've pioneered noninvasive testing in unlimited applications—each with their own potential to revolutionize care for patients. #TeamNatera includes clinicians, scientists, biostatisticians, researchers, and laboratory professionals from around the world. Our diverse teams blend a passion for patients with deep clinical, scientific, and technological roots. Natera’s tests are validated by more than 100 peer-reviewed publications that demonstrate high accuracy. Interested in joining us on our mission to change the management of disease worldwide? Visit https://www.natera.com/careers-at-natera to learn how you can become a part of our talented team. Natera operates ISO 13485-certified and CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendments (CLIA) in Austin, Texas and San Carlos, California. Please be advised that Natera will reach out to candidates with an @natera.com email domain ONLY. Email communications from all other domain names are not from Natera or its employees and are fraudulent. Natera does not request interviews via text messages and does not ask for personal information until a candidate has engaged with the company and has spoken to a recruiter and the hiring team. Natera takes cyber crimes seriously, and will collaborate with law enforcement authorities to prosecute any related cyber crimes. https://www.natera.com/privacy/
Founding Year
2004
Headquarters
Austin
,
United States
Sector(s)
No items found.
Funding State
Pre-Seed
Seed
Series A
Series B+
Exited
Total Funding Amount
$1,159.20M
Funds that Investested

Founders Fund

SF-based venture capital firm investing in science and technology companies solving difficult problems. The firm invests at all stages across a wide variety of sectors. Founders Fund pursues a founder-friendly investment strategy, providing maximum support with minimum interference.
Pre-Seed
Seed
Series A
Series B+
View Profile

Sequoia Capital

Helps the daring build legendary companies, from idea to IPO and beyond.
Pre-Seed
Seed
Series A
Series B+
View Profile
Investors that Investested

Roelof Botha

Partner, Sequoia Capital
Seed/Early-stage and growth investor. Looks for unconventional founders to add to his impressive investment portfolio. Invested in Youtube, Evernote, Tumblr, Instagram, MongoDB, 23&Me, etc.
Pre-Seed
Seed
Series A
Series B+
View Profile

James Healy

Managing Partner, Sofinnova
Pre-Seed
Seed
Series A
Series B+
View Profile

Andrew Chung

Founder and Managing Partner, 1955 Capital
Andrew has been a tech investor and entrepreneur for over 20 years with rare experience & success investing in health & sustainability. He was involved with 8 unicorns in world-positive sectors while at Khosla Ventures and Lightspeed Ventures that have created $30B+ of market value. He founded 1955 Capital to invest in revolutionary technologies to solve the greatest global challenges of our time.
Pre-Seed
Seed
Series A
Series B+
View Profile

Ravi Mhatre

Founder and Managing Director, Lightspeed Venture Partners
Ravi focuses on investments in enterprise IT, mobility, and Internet and cloud-based services and applications. Ravi has 17 years of venture capital experience and before entering venture capital, he ran a product management group at Silicon Graphics and also worked in management consulting at Booz Allen and as a software engineer for BDIS, a Silicon Valley biotech instruments manufacturer. His current investments include Nutanix, Appdynamics, Natera, Mulesoft, Sailpoint, Edgespring, TheFind and Kixeye, and has been recognized on the Forbes Midas List of top venture capital investors.
Pre-Seed
Seed
Series A
Series B+
View Profile

Brian Singerman

General Partner, Founders Fund
Invests across sectors and stages, with a passion for companies reinventing huge industries like healthcare, biotechnology and education. Board director for Solugen, Cloud9, Emerald Therapeutics and The Long-Term Stock Exchange, and a board observer for Anduril, Modern Health and Forward.
Pre-Seed
Seed
Series A
Series B+
View Profile

Browse All Sheets

Find lists for every type of VC
By Round
By Geography
By Sector
By Type
Sector-focused Sheets